[1]
T. KATSITADZE, N. KORSANTIA, L. BERIDZE, N. ADAMASHVILI, T. BOCHORISHVILI, and A. KATSITADZE, “THE IL-17 FAMILY OF CYTOKINES IMMUNOLOGICAL AND IMMUNOPATHOLOGICAL ASPECTS, PSORIASIS TREATMENT WITH IL-17 INHIBITOR – SECUKINUMAB”, jecmg, no. 1, pp. 132–137, Mar. 2025.